A Utility Tool for Personalised Medicine
Read more
Client Publications
On October 15, 2024 | By The Velsera Clinical and Compliance Team
Velsera Publications
On July 5, 2024 | By The Velsera Clinical and Compliance Team
Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence
Read more
Client Publications
On September 13, 2023 | By The Velsera Clinical and Compliance Team
Global impact of somatic structural variation on the cancer proteome
Read more
Client Publications
On September 7, 2023 | By The Velsera Clinical and Compliance Team
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
Read more
Client Publications
On August 28, 2023 | By The Velsera Clinical and Compliance Team
Pan-cancer atlas of somatic core and linker histone mutations
Read more
Velsera Publications
On July 24, 2023 | By The Velsera Clinical and Compliance Team
Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma
Read more
Velsera Publications
On June 20, 2023 | By The Velsera Clinical and Compliance Team
Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research
Read more
Client Publications
On May 16, 2023 | By The Velsera Clinical and Compliance Team
A comprehensive review and conceptual framework for cloud computing adoption in bioinformatics
Read more
Velsera Publications
On February 23, 2023 | By The Velsera Clinical and Compliance Team
Addressing barriers in FAIR data practices for biomedical data
Read more
Velsera Publications
On October 20, 2021 | By The Velsera Clinical and Compliance Team
NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease
Read more
Client Publications
On February 24, 2021 | By The Velsera Clinical and Compliance Team
Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach
Read more
Velsera Publications
On October 19, 2020 | By The Velsera Clinical and Compliance Team
Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
Read more